Positron Emission Tomography-Computed Tomography in a Case of POEMS Syndrome.

18F-fluorodeoxyglucose POEMS syndrome osteolytic lesion positron emission tomography-computed tomography

Journal

Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
ISSN: 0972-3919
Titre abrégé: Indian J Nucl Med
Pays: India
ID NLM: 8901274

Informations de publication

Date de publication:
Historique:
entrez: 5 2 2019
pubmed: 5 2 2019
medline: 5 2 2019
Statut: ppublish

Résumé

The POEMS syndrome is a rare and multisystemic disease characterized by the presence of polyneuropathy, organomegaly, endocrinopathy, presence of M protein, and alterations in the skin. The existence of bone lesions is frequent, being generally blastic or mixed and rarely lytic. We present the case of a 54-year-old male patient diagnosed with POEMS syndrome, with atypical presence of lytic lesions, who was referred for an 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) study for initial staging of the process. There were several hypermetabolic foci coinciding with bone lesions, reaching a maximum standardized uptake value of 15 at the level of the right iliac bone with associated soft-tissue mass. PET-CT is an adequate tool for evaluation, diagnosis, and monitoring of the pathology. The scan allows the detection and selection for its biopsy of bone lesions and lymphadenopathies.

Identifiants

pubmed: 30713387
doi: 10.4103/ijnm.IJNM_120_18
pii: IJNM-34-66
pmc: PMC6352633
doi:

Types de publication

Case Reports

Langues

eng

Pagination

66-68

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

Blood. 2003 Apr 1;101(7):2496-506
pubmed: 12456500
J Radiol. 2003 Apr;84(4 Pt 1):393-7
pubmed: 12759653
Brain. 2005 Aug;128(Pt 8):1911-20
pubmed: 15975949
Eur J Radiol. 2010 Nov;76(2):180-2
pubmed: 19581061
Lancet Oncol. 2014 Nov;15(12):e538-48
pubmed: 25439696
J Nucl Med. 2015 Sep;56(9):1334-7
pubmed: 26182964
Int J Clin Exp Med. 2015 May 15;8(5):7467-76
pubmed: 26221290
Skeletal Radiol. 2017 Jun;46(6):817-823
pubmed: 28343327
Hematol Oncol Clin North Am. 2018 Feb;32(1):119-139
pubmed: 29157614
Hematol Oncol Clin North Am. 2018 Feb;32(1):141-151
pubmed: 29157615

Auteurs

Jose Rafael Infante (JR)

Department of Nuclear Medicine, Hospital Infanta Cristina, Badajoz, Spain.

Lucía García (L)

Department of Nuclear Medicine, Hospital Infanta Cristina, Badajoz, Spain.

Juan Ignacio Rayo (JI)

Department of Nuclear Medicine, Hospital Infanta Cristina, Badajoz, Spain.

Justo Serrano (J)

Department of Nuclear Medicine, Hospital Infanta Cristina, Badajoz, Spain.

Manuel Moreno (M)

Department of Nuclear Medicine, Hospital Infanta Cristina, Badajoz, Spain.

Amparo Cobo (A)

Department of Nuclear Medicine, Hospital Infanta Cristina, Badajoz, Spain.

Pedro Jimenez (P)

Department of Nuclear Medicine, Hospital Infanta Cristina, Badajoz, Spain.

Andrés Martínez (A)

Department of Nuclear Medicine, Hospital Infanta Cristina, Badajoz, Spain.

Classifications MeSH